Clinical Trials on Plasma Cell Neoplasm in France
Total 11989 results
-
Institut Paoli-CalmettesCompletedMultiple Myeloma and Plasma Cell NeoplasmFrance
-
OncotherapeuticsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Institut Paoli-CalmettesUnknownLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Graft Versus Host DiseaseFrance
-
University Hospital, ToulouseInstitut Claudius RegaudRecruitingLymphoma | Neoplasm, Plasma CellFrance
-
Institut Paoli-CalmettesCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative NeoplasmsFrance
-
CTI BioPharmaNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
European Organisation for Research and Treatment...UnknownLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmFrance, Belgium, Netherlands, Germany, Italy
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
OncotherapeuticsWithdrawnStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
National Cancer Institute (NCI)CompletedDexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaMultiple Myeloma and Plasma Cell NeoplasmUnited States, Puerto Rico, South Africa
-
Centre Hospitalier Universitaire, AmiensCompletedMultiple MyelomaFrance
-
University Hospital, MontpellierNational Cancer Institute, FranceUnknownMetastatic Head-and-neck Squamous-cell CarcinomaFrance
-
SanofiRecruitingPlasma Cell Myeloma RefractoryFrance, Australia, Greece, Italy, Norway, United States, Portugal, Puerto Rico, Germany
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
Centre Hospitalier Universitaire de BesanconUnknownCompliance, Patient | Germ Cell Tumor | Follow-up | Text MessagingFrance
-
Hospices Civils de LyonRecruitingOropharyngeal Cancer | Circulating Tumor CellFrance
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; ScreenCell; Celen... and other collaboratorsUnknownMelanoma | Circulating Tumor CellFrance
-
Central Hospital, Nancy, FranceTerminatedStage IV Non-small Cell Lung Cancer | Stage IIIB Non Small Cell Lung CancerFrance
-
SanofiCompleted
-
Princess Maxima Center for Pediatric OncologyTakedaRecruitingAnaplastic Large Cell Lymphoma, ALK-Positive | Inflammatory Myofibroblastic Tumor | Other Solid TumorFrance, Netherlands
-
Centre Hospitalier Universitaire de BesanconPfizerActive, not recruitingKidney Neoplasms | Metastatic Renal Cell CancerFrance
-
SanofiTerminatedPlasma Cell MyelomaTaiwan, United States, Czechia, France, Greece, Spain
-
University Hospital, ToulouseCompleted
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
University Hospital, Strasbourg, FranceRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Hairy Cell Leukemia | Lymphoplasmacytic Lymphoma/Waldenström MacroglobulinemiaFrance
-
Centre Hospitalier Universitaire de BesanconCentre Hospitalier Universitaire Dijon; Centre Henri Becquerel; Maisonneuve-Rosemont... and other collaboratorsActive, not recruitingBlastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)France
-
SanofiCompletedPlasma Cell MyelomaFrance, Italy, Czechia, Greece, Spain, Canada, Australia, United States, Brazil, Hungary
-
Centre Hospitalier Universitaire de NiceCompleted
-
Institut de cancérologie Strasbourg EuropeHôpitaux Universitaires de Strasbourg; GENTYANE (GEnoTYpage and sequencing...Completed
-
Centre Hospitalier Universitaire de NiceInstitut National de la Santé Et de la Recherche Médicale, FranceCompleted
-
University Hospital, ToulouseTakeda; CelgeneTerminated
-
University Hospital, ToulouseUnknown
-
Centre Hospitalier Universitaire de NiceCompleted
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Nantes University HospitalRecruiting
-
University Hospital, CaenRecruiting
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Rennes University HospitalCompleted
-
University Hospital, ToulouseCelgene; Onyx Therapeutics, Inc.UnknownMultiple MyelomaFrance
-
AB ScienceCompleted
-
Centre René GauducheauCompleted
-
Nantes University HospitalTerminated
-
University Hospital, LilleCompleted
-
Nantes University HospitalTerminatedMultiple MyelomaFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Urinary Complications | Breast Adenocarcinoma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | Metastatic Malignant Neoplasm to the Bone | Musculoskeletal ComplicationUnited States, Puerto Rico
-
Nantes University HospitalWithdrawn
-
Centre Henri BecquerelRecruiting